Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,100 | N/A | 10,270 | 9,350 | 27,260 |
| Marketable Securities | 0 | N/A | 31,110 | 51,660 | 25,430 |
| Receivables | 3,430 | N/A | 9,210 | 9,770 | 65,230 |
| Inventories | 4,410 | N/A | 5,400 | 5,360 | 37,250 |
| Other current assets | 3,070 | 4,090 | 3,590 | 25,580 | 6,530 |
| TOTAL | $49,010 | $4,090 | $59,580 | $101,720 | $161,700 |
| Non-Current Assets | |||||
| PPE Net | 4,350 | N/A | 7,460 | 13,430 | 19,910 |
| Investments And Advances | 0 | 0 | 0 | 57,120 | 0 |
| Other Non-Current Assets | 32,880 | 39,920 | 56,310 | 51,200 | 243,900 |
| TOTAL | $37,230 | $39,920 | $63,770 | $121,750 | $263,810 |
| Total Assets | $86,260 | $44,010 | $123,360 | $223,490 | $425,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 40 | 770 | 710 | 790 |
| Accounts payable and accrued liabilities | 8,150 | 10,250 | 16,080 | 10,020 | 57,950 |
| Accrued Expenses | 3,760 | 3,430 | 0 | 0 | 0 |
| Other current liabilities | 6,320 | 7,630 | 5,370 | 5,570 | 0 |
| TOTAL | $19,260 | $22,150 | $22,250 | $16,310 | $62,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 140 | N/A | 0 | 700 | 135,740 |
| Other Non-Current Liabilities | 11,700 | 10,090 | 9,180 | 19,130 | 106,970 |
| TOTAL | $57,750 | $64,520 | $12,510 | $28,290 | $253,790 |
| Total Liabilities | $77,030 | $86,670 | $34,770 | $44,610 | $316,000 |
| Shareholders' Equity | |||||
| Common Shares | 41,200 | 30,560 | 30,560 | 168,460 | 130,340 |
| Retained earnings | -127,530 | N/A | -42,990 | -10,110 | -43,220 |
| Other shareholders' equity | 95,550 | 93,720 | 21,720 | 14,300 | 11,940 |
| TOTAL | $9,220 | $124,280 | $88,590 | $178,870 | $109,530 |
| Total Liabilities And Equity | $86,250 | $210,950 | $123,360 | $223,480 | $425,530 |